Ruthie Davi, vice president of statistics and regulatory innovation at Medidata, highlights the value of technology in rare ...
Rare disease is a major – and growing – area of clinical research and drug development. Of the FDA’s 46 novel drug approvals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results